HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Electronic disease surveillance for sensitive population groups - the diabetics case study.

Abstract
Diabetics are quite susceptible to infectious diseases and can easily spread them under certain circumstances. Their blood glucose levels are increased after infection and this can cause a hyperglycemic crisis. Our study indicates that this increase results in glucosylated hemoglobin elevation, even when a diabetic is monitored closely and his/her blood glucose is under tight control. Thus, it is important to detect infections at the very early stages of disease progression in order to aid the patient. For this purpose, an electronic Disease Surveillance System could be developed to collect and analyze blood glucose data. Generally, we could extend the use of blood glucose data to the implementation of disease surveillance systems for the general population.
AuthorsTaxiarchis Botsis, Ole Hejlesen, Johan Gustav Bellika, Gunnar Hartvigsen (Affiliation: Department of Computer Science, University of Tromsø, Norway. tbotsis at cs.uit.no)
JournalStudies in health technology and informatics (Stud Health Technol Inform) Vol. 136 Pg. 365-70 ( 2008) ISSN: 0926-9630 [Print] Netherlands
PMID18487758 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Hemoglobin A, Glycosylated
Topics
  • Adolescent
  • Adult
  • Blood Glucose (analysis)
  • Denmark
  • Diabetes Mellitus, Type 1 (blood)
  • Disease Progression
  • Female
  • Hemoglobin A, Glycosylated (analysis)
  • Humans
  • Male
  • Medical Records Systems, Computerized
  • Opportunistic Infections (blood, diagnosis, epidemiology)
  • Population Surveillance
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD